The percentage of CD19+/CD38hi/CD24hi/CD10+/IL-10+ was higher in pSS patients who had both clinical and serologic inactivity when compared to healthy subjects (P < 0.05) (Table 2; Figure 4F). This evidence concerns the gene CD19 and peeling skin syndrome.